|
1
|
Chansky K, Sculier JP, Crowley JJ, Giroux
D, Van Meerbeeck J and Goldstraw P; International Staging Committee
and Participating Institutions, : The International Association for
the Study of Lung Cancer Staging Project. Prognostic factors and
pathologic TNM stage in surgically managed non-small cell lung
cancer. Zhongguo Fei Ai Za Zhi Zhi stage in surgically managed
non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 13:9–18.
2010.(In Chinese). PubMed/NCBI
|
|
2
|
Sawabata N, Asamura H, Goya T, Mori M,
Nakanishi Y, Eguchi K, Koshiishi Y, Okumura M, Miyaoka E and Fujii
Y; Japanese Joint Committee for Lung Cancer Registry, : Japanese
Lung Cancer Registry Study: First prospective enrollment of a large
number of surgical and nonsurgical cases in 2002. J Thorac Oncol.
5:1369–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group, : Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sandler A, Gray R, Perry MC, Brahmer J,
Schiller JH, Dowlati A, Lilenbaum R and Johnson DH:
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell
lung cancer. N Engl J Med. 355:2542–2550. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Travis WD: Pathology of lung cancer. Clin
Chest Med. 32:669–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: miRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai J, Zhu X, Ma J and Wang W: miR-205
regulates A549 cells proliferation by targeting PTEN. Int J Clin
Exp Pathol. 8:1175–1183. 2015.PubMed/NCBI
|
|
15
|
Sun H, Ding C, Zhang H and Gao J: Let 7
miRNAs sensitize breast cancer stem cells to radiation induced
repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling
pathway. Mol Med Rep. 14:3285–3292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bracken CP, Gregory PA, Khew-Goodall Y and
Goodall GJ: The role of microRNAs in metastasis and
epithelial-mesenchymal transition. Cell Mol Life Sci. 66:1682–1699.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang BB, Xie H, Wu T, Xie N, Wu J, Gu Y,
Tang F and Liu J: Controlled-release mitomycin C-polylactic acid
film prevents epidural scar hyperplasia after laminectomy by
inducing fibroblast autophagy and regulating the expression of
miRNAs. Eur Rev Med Pharmacol Sci. 21:2526–2537. 2017.PubMed/NCBI
|
|
18
|
Keller A, Backes C, Leidinger P, Kefer N,
Boisguerin V, Barbacioru C, Vogel B, Matzas M, Huwer H, Katus HA,
et al: Next-generation sequencing identifies novel microRNAs in
peripheral blood of lung cancer patients. Mol Biosyst. 7:3187–3199.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai
B, Wang N, Li X, Feng T, Hong Y, et al: Downregulation of miR-133
and miR-590 contributes to nicotine-induced atrial remodelling in
canines. Cardiovasc Res. 83:465–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Z, Liu M, Stribinskis V, Klinge CM,
Ramos KS, Colburn NH and Li Y: MicroRNA-21 promotes cell
transformation by targeting the programmed cell death 4 gene.
Oncogene. 27:4373–4379. 2008. View Article : Google Scholar : PubMed/NCBI
|
